In mid-July, the FDA approved Leqembi, a series of injections that specifically target the plaques that build up in the brains of Alzheimer's patients. Those plaques are what cause the memory loss, behavioral changes, and terminal decline.

That medication was given to Gail Youngsdale. Three years ago, Gail's Alzheimer's disease was progressing. At the time, Leqembi was a trial drug. Doctors gave her injections to target the nine spots of plaque in her brain.

Now? They're gone and Gail has gotten married and gotten most of her memory back.

Every single spot of plaque is gone. 

Here's more:

Recommended
American Heroes of 9/11: Todd Beamer and the Passengers of Flight 93 Amy Curtis You Can Fight Back Against the Regime Media Kurt Schlichter

After being diagnosed with mild cognitive impairment and later early Alzheimer’s disease, Gail Youngdale feared what the future might hold. She’d seen the devastating effects of the disease on her own mother years ago. Seeking options, she enrolled in a landmark clinical trial for a therapy designed to remove toxic amyloid plaques, a hallmark of Alzheimer’s disease, from the brain.

Her daughter, Teri, served as her clinical trial study partner—attending every appointment, supporting Gail through the process, and learning as much as she could about Alzheimer’s and her own genetic risk of developing the disease.

 “After she was diagnosed with Alzheimer’s, I saw the fighter in my mom come out. She inspired me to take my own brain health seriously,” Teri said.

Today, Gail continues treatment with the now FDA-approved medication for early Alzheimer’s disease and has been able to maintain her independence and quality of life. She even found a second chance at love after reconnecting with her high school sweetheart.

This is a miracle.

Alzheimer's is an evil disease.

This writer lost an aunt to the disease. She developed symptoms in 2007 and died a decade later. It was a very sad thing to watch.

In this case, it seems it was.

It would be a miracle.

The FDA also approved a subcutaneous injection for home-use, too.